shortagewatch

Home / Digestive tract and metabolism / Insulin Lispro

ATC A10AD04 · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-Acting

Insulin Lispro shortage

As of 2 Nov 2026, Insulin Lispro has a reported shortage in 1 of the 16 countries we track (Japan), covering 2 products from 2 companies.

Countries1/16
Products2packs or presentations
Companies22 listed
Short since26 Jan 20269 months ago
Earliest returnnot givencompany estimate
Main reasonOther

Timeline

Japan
インスリン リスプロBS注ソロスター HU「サノフィ」インスリン リスプロBS注ソロスター HU「サノフィ」ヒューマログミックス50注ミリオペンヒューマログミックス50注ミリオペンtoday

Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.

Which companies are short

products short, all countries
Sanofi1 SANEli Lilly1 LLY

Listed: Sanofi SAN · Euronext Paris, Eli Lilly LLY · NYSE

Compared with similar medicines

ATC group A10AD · Insulins and Analogues for Injection, Intermediate- Or Long-Acting Combined with Fast-Acting
Insulin (Human)1/16Insulin Aspart1/16Insulin Lispro1/16

Affected products

CountryProductCompanySinceExpected backReason
インスリン リスプロBS注ソロスター HU「サノフィ」 limitedサノフィ26 Jan 2026not givenOther
ヒューマログミックス50注ミリオペン limited日本イーライリリー15 Oct 2026not givenIncreased demand

"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.